Who We Are

Craig Connors

Craig Connors, associate research analyst in the IBRI Diabetes Center’s Regenerative Medicine and Metabolic Disease group, runs a genotype analysis of lab mice DNA to determine which ones to use for various experiments.

Indiana’s life sciences economy comprises 1,751 companies employing 56,000 personnel with annual salaries of more than $97,000, and it makes a $79 billion annual economic contribution to the state. Indiana ranks 2nd in the nation with $10.2 billion in life sciences exports in 2018. Source: BioCrossroads.

Bringing together companies and universities

In 2012, Indiana state, civic, corporate and academic leaders called for the creation of an independent applied research institute to serve as a novel, mutually beneficial bridge between industry and academia.

The goal is to capture and accelerate game-changing, outcome-driven research—both industry sponsored and publicly funded—through the attraction and retention of world-class talent to the IBRI.

The IBRI exists to bring together companies and universities to work collaboratively on globally significant interrelated health issues with a disproportionate impact on Hoosiers: diabetes, metabolic disease and poor nutrition.

The IBRI’s laboratories and offices are housed in approximately 20,000-square feet of leased space in Indiana University School of Medicine’s Biotechnology Research and Training Center at 1345 W. 16th Street on Indianapolis’ near-westside, near the border of the planned 16 Tech Innovation District.

Following the groundbreaking ceremony last fall, the IBRI will eventually occupy 68,000 square feet of the new Advanced Research and Innovation Building in 16 Tech, including office, innovation, collaboration and laboratory space. Completion and move-in is scheduled for mid-2020.

See the IBRI leadership teams

Indiana specializes in four life sciences subsectors and showed steady growth in the drugs & pharmaceuticals and medical devices & equipment subsectors from 2014 to 2016.

4 Specialties Life Science Subsectors

Our mission

To become the leading independent, industry-inspired applied research institute focusing on the discovery and development of innovative solutions to improve health, targeting diabetes, metabolic disease and poor nutrition.

Our vision

Build a world-class organization that catalyzes activities across Indiana’s life sciences community and beyond.

Our values

Collaborative

We cannot do research alone—this is a team sport and a long game: the IBRI exists to enhance the robust life sciences ecosystem by bridging industry and academic research.

Teamwork

We work together as one team, both within and across our operations, and externally with our partners and stakeholders.

Innovative

We are focused on game-changing research to help solve the most persistent health problems and challenges.

Integrity

We do the right thing by adhering to the highest ethical standards and being honest, respectful, transparent, responsible and accountable.

Inclusive

We operate in a diverse ecosystem of colleagues, partners, stakeholders, and patients where we respect diversity in people and in ideas.

IBRI 2018 financial highlights

The IBRI utilizes external contractors and collaborators to the extent possible, so both full-time employees and operating expenses are understated for the research conducted. The Institute is developing research capabilities that will attract external funding from grants and sponsored research but the IBRI endowment will augment external funding. While research teams build and demonstrate their capabilities and are at the early stages of submitting proposals for external funding, the Institute has been more reliant on unrestricted contributions to fund expenditures than what is intended as the Institute matures.

Full-time employees at Dec. 31, 2018: 35
2018 operating expenses: $9.0 million
2018 capital expenditures: $1.2 million
Endowment balance at Dec. 31, 2018: $111.6 million

Every gift makes an impact.

Our research is made possible by your generous gift and it will help lead to solutions to major health challenges affecting almost one out of every three people globally.

donate now